Pneumococcal neuraminidases increase platelet killing by pneumolysin.


Journal

Thrombosis and haemostasis
ISSN: 2567-689X
Titre abrégé: Thromb Haemost
Pays: Germany
ID NLM: 7608063

Informations de publication

Date de publication:
19 Jul 2024
Historique:
medline: 20 7 2024
pubmed: 20 7 2024
entrez: 19 7 2024
Statut: aheadofprint

Résumé

Platelets prevent extravasation of capillary fluids into the pulmonary interstitial tissue by sealing gaps in inflamed endothelium. This reduces respiratory distress associated with pneumonia. Streptococcus pneumoniae is the leading cause of severe community-acquired pneumonia. Pneumococci produce pneumolysin (PLY), which forms pores in membranes of eukaryotic cells including platelets. Additionally, pneumococci express neuraminidases, which cleave sialic acid residues from eukaryotic glycoproteins. In this study, we investigated the effect of desialylation on PLY binding and pore formation on platelets. We incubated human platelets with purified neuraminidases and PLY, nonencapsulated D39/TIGR4 and isogenic mutants deficient for PLY and/or NanA. We assessed platelet desialylation, PLY binding and pore formation by flow cytometry. We also analyzed the inhibitory potential of therapeutic immunoglobulin G preparations. Pneumococci cause desialylation of platelet glycoproteins by neuraminidases, which is reduced by 90-100% in NanA-deficient mutants. NanC, cleaving only 2,3-linked sialic acid, induced platelet desialylation. PLY binding to platelets doubled (p=0.0166) and pore formation tripled (p=0.0373). A neuraminidase cleaving 2,3-, 2,6-, and 2,8-linked sialic acid like NanA was even more efficient. Addition of polyvalent IVIG decreased platelet desialylation induced by NanC up to 90% (p=0.263) and reduced pore formation >95% (p<0.0001) when incubated with pneumococci.

Sections du résumé

BACKGROUND BACKGROUND
Platelets prevent extravasation of capillary fluids into the pulmonary interstitial tissue by sealing gaps in inflamed endothelium. This reduces respiratory distress associated with pneumonia. Streptococcus pneumoniae is the leading cause of severe community-acquired pneumonia. Pneumococci produce pneumolysin (PLY), which forms pores in membranes of eukaryotic cells including platelets. Additionally, pneumococci express neuraminidases, which cleave sialic acid residues from eukaryotic glycoproteins. In this study, we investigated the effect of desialylation on PLY binding and pore formation on platelets.
MATERIAL AND METHODS METHODS
We incubated human platelets with purified neuraminidases and PLY, nonencapsulated D39/TIGR4 and isogenic mutants deficient for PLY and/or NanA. We assessed platelet desialylation, PLY binding and pore formation by flow cytometry. We also analyzed the inhibitory potential of therapeutic immunoglobulin G preparations.
RESULTS RESULTS
Pneumococci cause desialylation of platelet glycoproteins by neuraminidases, which is reduced by 90-100% in NanA-deficient mutants. NanC, cleaving only 2,3-linked sialic acid, induced platelet desialylation. PLY binding to platelets doubled (p=0.0166) and pore formation tripled (p=0.0373). A neuraminidase cleaving 2,3-, 2,6-, and 2,8-linked sialic acid like NanA was even more efficient. Addition of polyvalent IVIG decreased platelet desialylation induced by NanC up to 90% (p=0.263) and reduced pore formation >95% (p<0.0001) when incubated with pneumococci.

Identifiants

pubmed: 39029905
doi: 10.1055/a-2369-8680
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : DFG HA 3125/8-1 project no. 523973396 to SvH,Project no. 374031971 to AG and SvH - TRR 240

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest.

Auteurs

Kristin J Fritsch (KJ)

Department of Transfusion Medicine, Institute of Immunology and Transfusion Medicine, University Medicine Greifswald, Greifswald, Germany.

Laura Krüger (L)

Department of Transfusion Medicine, Institute of Immunology and Transfusion Medicine, University Medicine Greifswald, Greifswald, Germany.

Stefan Handtke (S)

Department of Transfusion Medicine, Institute of Immunology and Transfusion Medicine, University Medicine Greifswald, Greifswald, Germany.

Thomas Peter Kohler (TP)

Department of Molecular Genetics and Infection Biology, Universität Greifswald Mathematisch-Naturwissenschaftliche Fakultät, Greifswald, Germany.

Arina Ozhiganova (A)

Department of Molecular Genetics and Infection Biology, Universität Greifswald Mathematisch-Naturwissenschaftliche Fakultät, Greifswald, Germany.

Kristin Jahn (K)

Department of Molecular Genetics and Infection Biology, Universität Greifswald Mathematisch-Naturwissenschaftliche Fakultät, Greifswald, Germany.

Jan Wesche (J)

Department of Transfusion Medicine, Institute of Immunology and Transfusion Medicine, University Medicine Greifswald, Greifswald, Germany.

Andreas Greinacher (A)

Transfusion Medicine, Ernst-Moritz-Arndt-University, Greifswald, Germany.

Sven Hammerschmidt (S)

Department of Molecular Genetics and Infection Biology, Universität Greifswald Mathematisch-Naturwissenschaftliche Fakultät, Greifswald, Germany.

Classifications MeSH